Athanasios Skarpelos - 25 May 2022 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role
Director
Signature
/s/Athanasios Skarpelos
Issuer symbol
AVXL
Transactions as of
25 May 2022
Net transactions value
-$407,000
Form type
4
Filing time
27 May 2022, 20:30:22 UTC
Previous filing
04 Aug 2021
Next filing
29 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVXL Common Stock Options Exercise $46,000 +50,000 +3.8% $0.9200* 1,356,458 25 May 2022 Direct
transaction AVXL Common Stock Sale $453,000 -50,000 -3.7% $9.06 1,306,458 25 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVXL Stock Option (Right to Buy) Options Exercise $0 +50,000 $0.000000* 0 25 May 2022 Common Stock 50,000 $0.9200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.